Epsilon-Biotech SRL
Epsilon-Biotech reported total assets of 244,785 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Dec 2025).
The score of Epsilon-Biotech shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +110 % Total assets +36 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Epsilon-Biotech's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 17,279 € | ||||
| Equity | 220,466 € | ||||
| Cash | 91,519 € | ||||
| EBITDA | 38,174 € | ||||
| Total assets | 244,785 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 31 Dec 2025
- Year ended 30 Jun 2024filed on 02 Jan 2025
- Year ended 30 Jun 2023filed on 23 Jan 2024
- Year ended 30 Jun 2022filed on 23 Jan 2023
- Year ended 30 Jun 2021filed on 15 Dec 2021
Epsilon-Biotech's financial analysis
- Solvency90.1%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Epsilon-Biotech
Epsilon-Biotech's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0453.963.661
- VAT number
- BE0453963661
- Peppol
- Registered · 0208:0453963661 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Dec 1994
- Registered office
- 3520 Zonhoven
- Latest accounts
- 2025 · filed on 31 Dec 2025
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Epsilon-Biotech (SRL) has been based in Zonhoven since 1994, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 17,279 € and equity of 220,466 €; its revenue is not published. Its solvency stands at 90.1%, above the median of its sector (60.4%).
Companies similar to Epsilon-Biotech
Companies in the same business, of comparable size and area, outside its group.
- PGBioclin Research and experimental development on natural sciences and engineering Limbourg · balance sheet 208,043 €
- Sicher Research and experimental development on natural sciences and engineering Balen · balance sheet 246,186 €
- Biocli Consult Research and experimental development on natural sciences and engineering Jurbise · balance sheet 302,775 €
- GC Laboratory Europe Technical testing and analysis Leuven · balance sheet 406,216 €
- AnaLIStics Research and experimental development on natural sciences and engineering Kontich · balance sheet 208,698 €
- Danos Laboratory All other professional, scientific and technical activities n.e.c. Ixelles · balance sheet 297,522 €
- CliniCAP Diagnostic imaging services and medical laboratory activities Herzele · balance sheet 275,059 €
- Clinicanalytica Diagnostic imaging services and medical laboratory activities Ghent · balance sheet 211,030 €
Frequently asked questions about Epsilon-Biotech
What is the revenue of Epsilon-Biotech?
Epsilon-Biotech files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Epsilon-Biotech?
In Belgium, the VAT number is the company number prefixed with BE: BE0453963661 for Epsilon-Biotech, if the company is VAT-registered. Its company number (CBE) is 0453.963.661.
Where is the registered office of Epsilon-Biotech?
According to the CBE register, the registered office of Epsilon-Biotech is in 3520 Zonhoven.
What is the equity of Epsilon-Biotech?
At the close of the 2025 financial year, the equity of Epsilon-Biotech amounts to 220,466 €, a solvency of 90.1% of total assets.
Who manages Epsilon-Biotech?
The register lists 1 active mandates at Epsilon-Biotech. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Epsilon-Biotech
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →